UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Wealth Forward LLC

Wealth Forward LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 20.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,012 shares of the healthcare conglomerate’s stock after selling 255 shares during the period. UnitedHealth Group accounts for approximately 0.4% of Wealth Forward LLC’s portfolio, making the stock its 21st largest position. Wealth Forward LLC’s holdings in UnitedHealth Group were worth $512,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $27,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at about $32,000. Finally, Quarry LP lifted its position in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

UNH opened at $543.41 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market cap of $500.09 billion, a P/E ratio of 35.06, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a 50 day moving average of $541.04 and a two-hundred day moving average of $564.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the company posted $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on UNH shares. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Morgan Stanley decreased their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, UBS Group lowered their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.